Eye dropper

Outlook on the Dropper Global Market to 2027 - by Type, Material, Application and Geography - ResearchAndMarkets.com

Retrieved on: 
Monday, October 17, 2022

The dropper market is estimated to augment at a CAGR of 3.09% from a market value of US$1,210.671 million in 2020 to achieve a market value of US$ 1,497.792 million by the end of 2027.

Key Points: 
  • The dropper market is estimated to augment at a CAGR of 3.09% from a market value of US$1,210.671 million in 2020 to achieve a market value of US$ 1,497.792 million by the end of 2027.
  • The growing importance of essential oils is augmenting the market demand in the forecast period.
  • The rising prevalence of diseases that necessitate the administration of small amounts of drugs fuel market demand during the forecast period.
  • North America is projected to hold a significant market share in the global dropper market.

PULSEPOINT LAUNCHES HCP INTELLIGENCE SUITE WITH ONE-TO-ONE AUTOMATED TARGETING INFORMED BY CLINICAL AND DIGITAL INSIGHTS

Retrieved on: 
Tuesday, October 11, 2022

NEW YORK, Oct. 11, 2022 /PRNewswire/ -- PulsePoint, a technology company revolutionizing health decision-making in real time, today announced the launch of its HCP Intelligence Suite, a portfolio of unique clinical and media insights dashboards and smart optimization capabilities which enable marketers and traders to dynamically personalize healthcare professional (HCP) outreach in order to maximize campaign effectiveness and drive Rx impact. These analytics function as the connective tissue between campaign objectives, media performance and clinical impact, with automation technology to make these insights instantly actionable for brand marketers, media strategists and programmatic traders.

Key Points: 
  • Included in the suite are two new dashboards: HCP Clinical Insights and HCP Media Insights.
  • HCP Clinical Insights shows the correlation of media touchpoints and clinical impact by analyzing HCP exposure data in connection to Rx claims data.
  • HCP Media Insights provides real time information on how HCPs on and off-target lists are engaging with media.
  • As a result, the HCP Intelligence suite provides marketers with an actionable point of view of every healthcare professional across their digital and clinical journey.

iDrop Launches Same-Day South Florida Delivery Service for Home Improvement Products

Retrieved on: 
Tuesday, June 7, 2022

MELBOURNE, Fla., June 7, 2022 /PRNewswire/ -- iDrop, an on-demand home improvement delivery service, today announced the launch of its same-day delivery app that enables DIYers and professional contractors to get small to medium sized products and materials delivered right to their door in as soon as two hours. The app allows users to access real-time accurate inventory of their closest local Lowe's store across 16 locations in South Florida and place an order to have their desired product(s) delivered quickly, so they can focus on completing the project.

Key Points: 
  • "At iDrop, we believe that home improvement projects should be completed seamlessly and efficiently.
  • With 150+ hyper-local gig-economy drivers across South Florida, iDrop's competitive vetting process ensures users can experience the utmost customer service quality.
  • iDrop is a same-day delivery service for small to medium sized home improvement products and materials from the user's local home improvement store, getting them what they need to get the job done in less time from the store, straight to their door.
  • iDrop was created by a team of pro construction and technology professionals and weekend DIYers dedicated to transforming the home improvement industry in South Florida with fast, reliable delivery service that helps DIYers and professionals so projects are completed in a timely manner.

$41.66 Bn Low Density Polyethylene (LDPE) Extrusion Markets - Global Forecasts to 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, May 23, 2022

The "Low Density Polyethylene (LDPE) Extrusion Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Low Density Polyethylene (LDPE) Extrusion Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The main driving factor for the market growth of the low-density polyethylene extrusion market is the packaging sector.
  • Low-density polyethylene extrusion (LDPE) is a type of thermoplastic that is made up of monomer ethylene.
  • Due to these properties, low-density polyethylene extrusion is known to be the best application for manufacturing containers, moulded laboratory equipment, dispensing bottles, and wash bottles.

WWP Beauty Launches New E-Catalog

Retrieved on: 
Wednesday, December 15, 2021

Los Angeles, Dec. 15, 2021 (GLOBE NEWSWIRE) -- WWP Beauty, a world-class full-service supplier to the global beauty industry, is announcing the launch of its new online stock catalog.

Key Points: 
  • Los Angeles, Dec. 15, 2021 (GLOBE NEWSWIRE) -- WWP Beauty, a world-class full-service supplier to the global beauty industry, is announcing the launch of its new online stock catalog.
  • WWP Beauty will be expanding the e-catalog in early 2022 with Accessories, Turnkey Collections, and Formulations to showcase our full-service capabilities and further solidify our mission of being, the source for everything beauty, said Musa Dias, WWP Beauty, CMO
    WWP Beauty strives to create a more clean, inclusive, and sustainable future.
  • View the new catalog on the WWP Beauty website by visiting: https://catalog.wwpbeauty.com/
    WWP Beauty is committed to developing future-focused, sustainable solutions for the global beauty industry through close collaboration, exceptional agility, and unparalleled scale.
  • Through a worldwide team of beauty experts that span across North America, EMEA, and APAC, WWP Beauty offers their customers global support at the local level.

Impel NeuroPharma Announces Publication of Pivotal Phase 3, Open-Label Stop 301 Study of INP104 (TRUDHESA™) for Treatment of Acute Migraine in the Journal Headache

Retrieved on: 
Monday, August 9, 2021

SEATTLE, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) diseases who have high unmet medical needs, announced today that its pivotal Phase 3, open-label study, STOP 301, was published in the August 7, 2021 edition of Headache: The Journal of Head and Face Pain, the official journal of the American Headache Society. TRUDHESA™ (INP104) is dihydroergotamine mesylate (DHE) delivered directly into the vascular-rich upper nasal space using Impel’s proprietary Precision Olfactory Delivery (POD®) technology for the treatment of acute migraine.

Key Points: 
  • TRUDHESA (INP104) is dihydroergotamine mesylate (DHE) delivered directly into the vascular-rich upper nasal space using Impels proprietary Precision Olfactory Delivery (POD) technology for the treatment of acute migraine.
  • I am pleased to see pivotal data demonstrating that INP104 was both safe and tolerable with long-term use.
  • TRUDHESA-related treatment-emergent AEs were reported by 36.7 percent of patients, and 6.8 percent discontinued treatment due to AEs over 24 weeks.
  • Impel, POD and the Impel logo are trademarks of Impel NeuroPharma, Inc. To learn more about Impel NeuroPharma, please visit our website at https://impelnp.com/ .

Technomed: New coronavirus antigen self-test approved for use in UK as government looks to increase capacity for rapid testing

Retrieved on: 
Tuesday, April 13, 2021

Only with the full certification process can the quality and reliability that end users expects and deserves be demonstrated.

Key Points: 
  • Only with the full certification process can the quality and reliability that end users expects and deserves be demonstrated.
  • "\nSales planning in the UK is already underway, with availability of the self-test already in place.
  • The product consists of test cassettes, swabs, vial with extraction solution, tube with dropper cap and instructions for private use.
  • The COVID-19-antigen self-test has already received special approval from the German Medicines and Healthcare products Regulatory Agency on 24.02.2021.

Dropper Market to Grow by USD 52.40 Million During 2021-2025 | Growing Need for Innovative Cosmetic Packaging to Boost Market Growth | Technavio

Retrieved on: 
Tuesday, March 30, 2021

The dropper market is expected to grow by USD 52.40 million during 2021-2025, expanding at a CAGR of about 5%.

Key Points: 
  • The dropper market is expected to grow by USD 52.40 million during 2021-2025, expanding at a CAGR of about 5%.
  • Dropper Market: Growing need for innovative cosmetic packaging to drive growth.
  • Hence, the growing need for innovative cosmetic packaging is expected to drive the growth of the market during the forecast period.
  • "Improvements in healthcare infrastructure and the need for advanced vaccinations and medicines will further boost market growth during the forecast period", says a senior analyst at Technavio.

Global Droppers Market, 2018-2027: Drivers, Constraints, Opportunities, Threats & Challenges During this Period - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 15, 2020

Growth in drug development and the consequent need for accurate and precise dispensing equipment are likely t- boost the growth of the droppers market.

Key Points: 
  • Growth in drug development and the consequent need for accurate and precise dispensing equipment are likely t- boost the growth of the droppers market.
  • However, increasing waste generation, emission, and government regulations are likely t- hamper the profit boundaries.
  • Droppers are Food and Drug Administration (FDA), USA compliant which ensures the highest quality of the products.
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
    Company profiling with detailed strategies, financials, and recent developments